Stay updated on Bristol Myers Squibb Press Releases
Sign up to get notified when there's something new on the Bristol Myers Squibb Press Releases page.

Latest updates to the Bristol Myers Squibb Press Releases page
- Check3 days agoChange DetectedNew June 2 and June 1 press releases were added, including Izalontamab Brengitecan results, Camzyos priority review for adolescents, and Opdivo label expansion, all under Corporate/Financial News. Older May–April 2026 releases were removed from the feed.SummaryDifference9%

- Check10 days agoChange DetectedTwo new press releases were added to the newsroom listing for May 21 and May 20, 2026, highlighting upcoming ASCO data and a strategic Anthropic collaboration. Two older March 2026 items were removed from the listing, altering the historical content shown on the page.SummaryDifference12%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThree new press-release entries were added to the listing for May 2026, reflecting recent company announcements. Three older March 2026 items were removed, updating the feed to show the latest news.SummaryDifference10%

- Check32 days agoChange DetectedTwo new press releases were added (May 4, 2026 and April 30, 2026) and two March 2026 items were removed from the listings, updating the press releases timeline.SummaryDifference10%

- Check39 days agoChange DetectedAdds a press release stating that Bristol Myers Squibb and Pfizer will make Eliquis available via the Mark Cuban Cost Plus Drug Company (April 24, 2026). Removes an older press release about izalontamab brengitecan topline results (February 26, 2026) from the press releases listing.SummaryDifference3%

- Check61 days agoChange DetectedNew press release entries have been added to the listing, showing titles, dates, categories, and read-more links. This expands the catalog of company news displayed on the page.SummaryDifference54%

Stay in the know with updates to Bristol Myers Squibb Press Releases
Enter your email address, and we'll notify you when there's something new on the Bristol Myers Squibb Press Releases page.